Читать книгу Evidence in Medicine - Iain K. Crombie - Страница 16

1 1. Porter, R. (1999). The Greatest Benefit to Mankind. London: Harpers Collins.

2 2. Cantu, J.Q. (1965). Benjamin Franklin's medical imprints. Bull. Med. Libr. Assoc. 53: 71–79.

3 3. Bhatt, A. (2010). Evolution of clinical research: a history before and beyond Lames Lind. Perspect. Clin. Res. 1: 6–10.

4 4. Ackerknecht, E.H. (1982). A Short History of Medicine. Baltimore: Johns Hopkins University Press.

5 5. DePalma, R.G., Hayes, V.W., and Zacharski, L.R. (2007). Bloodletting: past and present. J. Am. Coll. Surg. 205: 132–144.

6 6. Risse, G.B. (1979). Renaissance of bloodletting – chapter in modern therapeutics. J. Hist. Med. Allied Sci. 34: 3–22.

7 7. Stokes, W. (1865). The address in medicine. BMJ ii: 133–142.

8 8. Biggio, J.R. Jr. (2013). Bed rest in pregnancy: time to put the issue to rest. Obstet. Gynecol. 121: 1158–1160.

9 9. Sprague, A.E. (2004). The evolution of bed rest as a clinical intervention. J. Obstet. Gynecol. Neonatal. Nurs. 33: 542–549.

10 10. Bigelow, C. and Stone, J. (2011). Bed rest in pregnancy. Mt Sinai J. Med. 78: 291–302.

11 11. McCall, C.A., Grimes, D.A., and Lyerly, A.D. (2013). ‘Therapeutic’ bed rest in pregnancy: unethical and unsupported by data. Obstet. Gynecol. 121: 1305–1308.

12 12. Brower, R.G. (2009). Consequences of bed rest. Crit. Care Med. 37: S422–S428.

13 13. Jack, D.B. (1997). One hundred years of aspirin. Lancet 350: 437–439.

14 14. Montinari, M.R., Minelli, S., and De Caterina, R. (2019). The first 3500years of aspirin history from its roots – a concise summary. Vasc. Pharmacol. 113: 1–8.

15 15. Vane, J.R., Flower, R.J., and Botting, R.M. (1990). History of aspirin and its mechanism of action. Stroke 21: IV12–IV23.

16 16. Rosenfeld, L. (2002). Insulin: discovery and controversy. Clin. Chem. 48: 2270–2288.

17 17. Banting, F.G. (1926). An address on diabetes and insulin: being the Nobel lecture delivered at Stockholm on September 15th, 1925. CMAJ 16: 221–232.

18 18. Banting, F.G., Best, C.H., Collip, J.B. et al. (1922). Pancreatic extracts in the treatment of diabetes mellitus. CMAJ 12: 141–146.

19 19. Karamitsos, D.T. (2011). The story of insulin discovery. Diabetes Res. Clin. Pract. 93 (Suppl 1): S2–S8.

20 20. Wangensteen, O.H., Wangensteen, S.D., and Klinger, C.F. (1972). Wound management of Ambroise pare and Dominique Larrey, great French military surgeons of the 16th and 19th centuries. Bull. Hist. Med. 46: 207–234.

21 21. Drucker, C.B. (2008). Ambroise pare and the birth of the gentle art of surgery. Yale J. Biol. Med. 81: 199–202.

22 22. Huth, E. (2006). Quantitative evidence for judgments on the efficacy of inoculation for the prevention of smallpox: England and New England in the 1700s. J. R. Soc. Med. 99: 262–266.

23 23. Bird, A. (2019). James Jurin and the avoidance of bias in collecting and assessing evidence on the effects of variolation. J. R. Soc. Med. 112: 119–123.

24 24. Charles, D. and Larsen, B. (1986). Streptococcal puerperal sepsis and obstetric infections: a historical perspective. Rev. Infect. Dis. 8: 411–422.

25 25. Adriaanse, A.H., Pel, M., and Bleker, O.P. (2000). Semmelweis: the combat against puerperal fever. Eur. J. Obstet. Gynecol. Reprod. Biol. 90: 153–158.

26 26. Chalmers, I., Dukan, E., Podolsky, S. et al. (2012). The advent of fair treatment allocation schedules in clinical trials during the 19th and early 20th centuries. J. R. Soc. Med. 105: 221–227.

27 27. Burnby, J. and Bierman, A. (1996). The incidence of scurvy at sea and its treatment. Rev. Hist. Pharm. 44: 339–346.

28 28. Baron, J.H. (2009). Sailors' scurvy before and after James Lind – a reassessment. Nutr. Rev. 67: 315–332.

29 29. Milne, I. (2012). Who was James Lind, and what exactly did he achieve. J. R. Soc. Med. 105: 503–508.

30 30. Bartholomew, M. (2002). James Lind's treatise of the scurvy (1753). Postgrad. Med. J. 78: 695–696.

31 31. Boylston, A.W. (2002). Clinical investigation of smallpox in 1767. N. Engl. J. Med. 346: 1326–1328.

32 32. Boylston, A. (2014). William Watson's use of controlled clinical experiments in 1767. J. R. Soc. Med. 107: 246–248.

33 33. Donaldson, I.M. (2016). Van Helmont's proposal for a randomised comparison of treating fevers with or without bloodletting and purging. J. R. Coll. Physicians Edinb. 46: 206–213.

34 34. Chalmers, I. and Toth, B. (2009). Nineteenth‐century controlled trials to test whether belladonna prevents scarlet fever. J. R. Soc. Med. 102: 549–550.

35 35. Hrobjartsson, A., Gotzsche, P.C., and Gluud, C. (1998). The controlled clinical trial turns 100 years: Fibiger's trial of serum treatment of diphtheria. BMJ 317: 1243–1245.

36 36. Podolsky, S.H. (2009). Jesse Bullowa, specific treatment for pneumonia, and the development of the controlled clinical trial. J. R. Soc. Med. 102: 203–207.

37 37. MRC (1934). The serum treatment of lobar pneumonia: a report of the therapeutic trials Committee of the Medical Research Council. BMJ 1: 241–245.

38 38. Lorriman, G. and Martin, W.J. (1950). Trial of antistin in the common cold. BMJ 2: 430–431.

39 39. MRC (2004). Clinical trial of patulin in the common cold. 1944. Int. J. Epidemiol. 33: 243–246.

40 40. Hill, A.B. (1990). Suspended judgment. Memories of the British streptomycin trial in tuberculosis. The first randomized clinical trial. Control. Clin. Trials 11: 77–79.

41 41. MRC (1951). Prevention of whooping‐cough by vaccination; a Medical Research Council investigation. BMJ 1: 1463–1471.

42 42. MRC (1948). Streptomycin treatment of pulmonary tuberculosis. BMJ 2: 769–782.

43 43. MRC (1950). Clinical trials of antihistaminic drugs in the prevention and treatment of the common cold; report by a special committee of the Medical Research Council. BMJ 2: 425–429.

44 44. Editorial (1948). The controlled therapeutic trial. BMJ 2: 791–792.

45 45. MRC (1950). Treatment of pulmonary tuberculosis with streptomycin and Para‐aminosalicylic acid; a Medical Research Council investigation. BMJ 2: 1073–1085.

46 46. Murray, J.F., Schraufnagel, D.E., and Hopewell, P.C. (2015). Treatment of tuberculosis. A historical perspective. Ann. Am. Thorac. Soc. 12: 1749–1759.

47 47. Lanska, D.J. and Lanska, J.T. (2007). Franz Anton Mesmer and the rise and fall of animal magnetism: dramatic cures, controversy, and ultimately a triumph for the scientific method. In: Brain, Mind and Medicine: Essays in Eighteenth‐Century Neuroscience (eds. H. Whitaker, C.U.M. Smith and S. Finger), 301–320. New York: Springer https://doi.org/10.1007/978‐0‐387‐70967‐3.

48 48. Donaldson, I.M. (2005). Mesmer's 1780 proposal for a controlled trial to test his method of treatment using “animal magnetism”. J. R. Soc. Med. 98: 572–575.

49 49. Dimond, E.G., Kittle, C.F., and Crockett, J.E. (1960). Comparison of internal mammary artery ligation and sham operation for angina pectoris. Am. J. Cardiol. 5: 483–486.

50 50. Cobb, L.A., Thomas, G.I., Dillard, D.H. et al. (1959). An evaluation of internal‐mammary‐artery ligation by a double‐blind technic. N. Engl. J. Med. 260: 1115–1118.

51 51. Enck, P., Bingel, U., Schedlowski, M. et al. (2013). The placebo response in medicine: minimize, maximize or personalize? Nat. Rev. Drug Discov. 12: 191–204.

52 52. Horing, B., Weimer, K., Muth, E.R. et al. (2014). Prediction of placebo responses: a systematic review of the literature. Front. Psychol. https://doi.org/10.3389/fpsyg.2014.01079.

53 53. Passamani, E. (1991). Clinical trials – are they ethical? N. Engl. J. Med. 324: 1589–1592.

54 54. Schimmel, E.M. (1963). The physician as pathogen. J. Chronic Dis. 16: 1–4.

55 55. Beeson, P.B. (1980). Changes in medical therapy during the past half century. Medicine 59: 79–99.

56 56. Mafi, J.N. and Parchman, M. (2018). Low‐value care: an intractable global problem with no quick fix. BMJ Qual. Saf. 27: 333–336.

57 57. Levinson, W., Kallewaard, M., Bhatia, R.S. et al. (2015). ‘Choosing Wisely’: a growing international campaign. BMJ Qual. Saf. 24: 167–174.

58 58. Best, M. and Neuhauser, D. (2005). Pierre Charles Alexandre Louis: master of the spirit of mathematical clinical science. Qual. Saf. Health Care 14: 462–464.